In the News - 340B Matters
paged,page-template,page-template-blog-large-image,page-template-blog-large-image-php,page,page-id-15484,paged-3,page-paged-3,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

340B in the News

05 Sep Medium: What’s the deal with 340B?

"In 2014, 65.1 million people were insured by Medicaid, and the government program spent approximately $42 billion on prescription drugs. With that much money flying around, it’s not surprising that nearly 550 drug manufacturers are participating in the rebate program, given that it is a...

Read More

16 Jul Opinion: Drug Pricing Program Strengthens Health Care

"Vidant Health, like hospital systems around the nation, serves a critical role as a health care safety net, providing high-quality care to all patients, including those who are under or uninsured. According to the 2015 Small Area Income and Poverty Estimates, 28 of the 29 counties...

Read More

12 Jul Opinion: Drug Savings Help Needy Patients

"Lifespan’s hospitals, like many hospitals around the nation, serve a critical role as a health-care safety net, providing high-quality care to all patients, regardless of their ability to pay. We provide vital, one-of-a-kind services for our community, including a trauma center, a burn unit, cancer...

Read More

06 Jul Politico: Drugmakers defy Trump’s call to drop prices

"President Donald Trump in May said that drugmakers would soon announce “massive” price cuts, and his administration rolled out a plan to bring down the cost of medicines. But the companies don’t appear to have gotten that message. Bayer raised the price of two cancer drugs...

Read More

Want To Stay Up-To-Date On The Latest 340B News?